However, it appears that ADAM10 is the major α-secretase cleavage enzyme [45, 49], as even moderate neuronal overexpression was shown to strongly stimulate α-secretase cleavage of APP, delaying plaque formation, and alleviating cognitive defects in a transgenic AD mouse model [52, 53]. Here, APP is linked to Alzheimer disease.